Anne-Aurélie Lopes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anne-Aurélie Lopes has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Alexandra Tielli
Pediatric Emergency Department AP‐HP, Robert Debre Hospital University, Paris City University Paris France
2 shared publications- Alexis Mosca
Department of Pediatric Gastroenterology and Nutrition Robert‐Debré Hospital, APHP Paris France
1 shared publication - Anaïs Lemoine
Pediatric Nutrition and Gastroenterology Department, AP-HP, Trousseau Hospital, Sorbonne Université, Paris, France
1 shared publication - Anne-Sophie Parentelli
Service de Pédiatrie, CHU Félix Guyon Saint‐Denis France
1 shared publication - Bruno Dupuy
Pathogenesis of Bacterial Anaerobes, Institut Pasteur, Université Paris-Cité, UMR-CNRS 6047
1 shared publication - Claire Ferrua
Paediatric Emergency Department, AP-HP, Robert Debré Hospital, Université Paris Cité, 48 Boulevard Sérurier, 75019 Paris, France
1 shared publication
Latest Publications
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Antibiotic tolerance and biofilm formation in the anaerobic intestinal symbiont, bacteroides thetaiotaomicron
Tolérance aux antibiotiques et formation de biofilm chez le symbiote intestinal anaérobie, bacteroides thetaiotaomicron: Le microbiote intestinal humain impacte notre santé via son rôle dans les fonctions digestives, métaboliques, immunitaires et même neurologiques. Sa composition est dominée par les phyla Firmicutes et Bacteroidetes, dont l'un des membres les plus abondants est la bactérie commensale et strictement anaérobie Bacteroides thetaiotaomicron. Transmise de la mère à l'enfant, B. thetaiotaomicron favorise dès la période néonatale le développement de l'épithélium intestinal et du système immunitaire et joue ensuite un rôle clé dans la dégradation des polysaccharides complexes non métabolisables par l'hôte. En cas de déséquilibre du microbiote (dysbiose), provoqué par exemple par un traitement antibiotique, la baisse du contrôle assuré par les populations commensales en général, et par B. thetaiotaomicron en particulier, favorise l'implantation de pathogènes intestinaux tels que Clostridioides difficile, bactérie à l'origine de sévères diarrhées. Par ailleurs, la diminution de l'abondance des Bacteroides, dont B. thetaiotaomicron, est aussi corrélée à l'apparition de maladies intestinales inflammatoires chroniques et d'obésité. Alors que les communautés de bactéries intestinales adoptent un mode de vie proche du biofilm (communautés de bactéries agrégées entres elles), la formation de biofilm et la tolérance aux antibiotiques ont principalement été étudiées chez des bactéries pathogènes aérobies ou aérobies facultatives (Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, etc.) en raison des préoccupations cliniques majeures qu'elles engendrent. Pourtant le biofilm et l'antibio-tolérance induite par les biofilms des bactéries commensales pourraient être impliqués dans plusieurs aspects bénéfiques importants, depuis la colonisation chez les nouveau-nés, jusqu'à la résilience aux dysbioses antibiotiques et ainsi contribuer à la prévention des infections secondaires opportunistes ou de certaines maladies inflammatoires chroniques. Lors de ma thèse, je me suis intéressée à la formation de biofilm chez B. thetaiotaomicron, tout d'abord en contribuant à une étude portant sur le rôle des sels biliaires dans l'induction de la formation de biofilm chez B. thetaiotaomicron et l'importance de la dégradation de l'ADN par une nucléase extracellulaire (BT3563). Je me suis ensuite intéressée au rôle potentiel des pompes à efflux dans la formation de biofilm. Après avoir montré que le phénylalanine-arginine ß-naphthylamide (PAßN), un inhibiteur global des pompes à efflux de type RND, inhibe la formation de biofilm dépendant des sels biliaires, j'ai réalisé un crible de ces pompes à efflux et mis en évidence le rôle de la pompe BT3337-39, dont l'expression est induite par la présence de sels biliaires, ainsi que du régulateur transcriptionnel, appartenant à la famille AraC, BT1847. J'ai ensuite mis en évidence le lien entre cette pompe, ce régulateur, la concentration extracellulaire en magnésium et le profil en ADN de la matrice extracellulaire. J'ai aussi démontré in vitro que la formation de biofilm entraîne une tolérance aux antibiotiques à des concentrations très élevées dans la souche de laboratoire VPI5482 mais aussi chez certains isolats cliniques formant du biofilm. L'implication de cette antibio-tolérance induite par le biofilm dans la limitation des dysbioses aux antibiotiques et les infections secondaires à C. difficile est actuellement testée en minibioréacteurs (MBRA), un système de culture in vitro qui permet de tester l'effet de l'antibio-tolérance de nos souches en présence de communautés microbiennes fécales complexes, ainsi que in vivo dans un modèle murin. Au-delà de ses aspects fondamentaux, ce projet pourrait, à terme, mener à la conception d'indicateurs prédictifs de dysbiose ou de stratégies raisonnées de conception de souches probiotiques de B. thetaiotaomicron, susceptibles de réduire l'impact négatif d'évènements dysbiotiques.
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Antibiotic tolerance and biofilm formation in the anaerobic intestinal symbiont, bacteroides thetaiotaomicron
Tolérance aux antibiotiques et formation de biofilm chez le symbiote intestinal anaérobie, bacteroides thetaiotaomicron: Le microbiote intestinal humain impacte notre santé via son rôle dans les fonctions digestives, métaboliques, immunitaires et même neurologiques. Sa composition est dominée par les phyla Firmicutes et Bacteroidetes, dont l'un des membres les plus abondants est la bactérie commensale et strictement anaérobie Bacteroides thetaiotaomicron. Transmise de la mère à l'enfant, B. thetaiotaomicron favorise dès la période néonatale le développement de l'épithélium intestinal et du système immunitaire et joue ensuite un rôle clé dans la dégradation des polysaccharides complexes non métabolisables par l'hôte. En cas de déséquilibre du microbiote (dysbiose), provoqué par exemple par un traitement antibiotique, la baisse du contrôle assuré par les populations commensales en général, et par B. thetaiotaomicron en particulier, favorise l'implantation de pathogènes intestinaux tels que Clostridioides difficile, bactérie à l'origine de sévères diarrhées. Par ailleurs, la diminution de l'abondance des Bacteroides, dont B. thetaiotaomicron, est aussi corrélée à l'apparition de maladies intestinales inflammatoires chroniques et d'obésité. Alors que les communautés de bactéries intestinales adoptent un mode de vie proche du biofilm (communautés de bactéries agrégées entres elles), la formation de biofilm et la tolérance aux antibiotiques ont principalement été étudiées chez des bactéries pathogènes aérobies ou aérobies facultatives (Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, etc.) en raison des préoccupations cliniques majeures qu'elles engendrent. Pourtant le biofilm et l'antibio-tolérance induite par les biofilms des bactéries commensales pourraient être impliqués dans plusieurs aspects bénéfiques importants, depuis la colonisation chez les nouveau-nés, jusqu'à la résilience aux dysbioses antibiotiques et ainsi contribuer à la prévention des infections secondaires opportunistes ou de certaines maladies inflammatoires chroniques. Lors de ma thèse, je me suis intéressée à la formation de biofilm chez B. thetaiotaomicron, tout d'abord en contribuant à une étude portant sur le rôle des sels biliaires dans l'induction de la formation de biofilm chez B. thetaiotaomicron et l'importance de la dégradation de l'ADN par une nucléase extracellulaire (BT3563). Je me suis ensuite intéressée au rôle potentiel des pompes à efflux dans la formation de biofilm. Après avoir montré que le phénylalanine-arginine ß-naphthylamide (PAßN), un inhibiteur global des pompes à efflux de type RND, inhibe la formation de biofilm dépendant des sels biliaires, j'ai réalisé un crible de ces pompes à efflux et mis en évidence le rôle de la pompe BT3337-39, dont l'expression est induite par la présence de sels biliaires, ainsi que du régulateur transcriptionnel, appartenant à la famille AraC, BT1847. J'ai ensuite mis en évidence le lien entre cette pompe, ce régulateur, la concentration extracellulaire en magnésium et le profil en ADN de la matrice extracellulaire. J'ai aussi démontré in vitro que la formation de biofilm entraîne une tolérance aux antibiotiques à des concentrations très élevées dans la souche de laboratoire VPI5482 mais aussi chez certains isolats cliniques formant du biofilm. L'implication de cette antibio-tolérance induite par le biofilm dans la limitation des dysbioses aux antibiotiques et les infections secondaires à C. difficile est actuellement testée en minibioréacteurs (MBRA), un système de culture in vitro qui permet de tester l'effet de l'antibio-tolérance de nos souches en présence de communautés microbiennes fécales complexes, ainsi que in vivo dans un modèle murin. Au-delà de ses aspects fondamentaux, ce projet pourrait, à terme, mener à la conception d'indicateurs prédictifs de dysbiose ou de stratégies raisonnées de conception de souches probiotiques de B. thetaiotaomicron, susceptibles de réduire l'impact négatif d'évènements dysbiotiques.
- 27 August 2025
- Published by Wiley in Acta Paediatrica
- Vol. 115 (1) , 117-125
Caffeine Was Associated With Shorter Continuous Positive Airway Pressure Treatment for Infants up to Eight Weeks Old Hospitalised for Bronchiolitis
Aim: Bronchiolitis is the leading cause of hospitalisation before 1 year of age, with no treatment available, while caffeine stimulates respiratory function in young infants. This pilot study investigated the impact of caffeine on infants up to 8‐week‐old hospitalised for bronchiolitis, regardless of apnoea. Method: An observational study was conducted from October 2021 to February 2022 and from October 2022 to February 2023 in two Paris hospitals. The outcomes included adverse events and the need for, and duration of, ventilatory support and nutritional support. Results: We recruited 186 patients (55% boys) at a median age of 4.5 weeks. The 65 patients who received caffeine required nutritional support significantly less often than the no caffeine group ( p < 0 .001). The duration of continuous positive airway pressure (CPAP) was significantly shorter in patients in the caffeine group (4.1 days) than in the no caffeine group (7.1 days) ( p = 0.003 ). There was a nonsignificant shorter duration of nutritional support in those who required ventilatory support ( p = 0.05 ) . Caffeine was well tolerated. Conclusion: Caffeine reduced the duration of CPAP and the need for and duration of nutritional support through a direct effect on the digestive system or overall improvement. These results should be confirmed by randomised trials.
- 27 August 2025
- Published by Wiley in Acta Paediatrica
- Vol. 115 (1) , 117-125
Caffeine Was Associated With Shorter Continuous Positive Airway Pressure Treatment for Infants up to Eight Weeks Old Hospitalised for Bronchiolitis
Aim: Bronchiolitis is the leading cause of hospitalisation before 1 year of age, with no treatment available, while caffeine stimulates respiratory function in young infants. This pilot study investigated the impact of caffeine on infants up to 8‐week‐old hospitalised for bronchiolitis, regardless of apnoea. Method: An observational study was conducted from October 2021 to February 2022 and from October 2022 to February 2023 in two Paris hospitals. The outcomes included adverse events and the need for, and duration of, ventilatory support and nutritional support. Results: We recruited 186 patients (55% boys) at a median age of 4.5 weeks. The 65 patients who received caffeine required nutritional support significantly less often than the no caffeine group ( p < 0 .001). The duration of continuous positive airway pressure (CPAP) was significantly shorter in patients in the caffeine group (4.1 days) than in the no caffeine group (7.1 days) ( p = 0.003 ). There was a nonsignificant shorter duration of nutritional support in those who required ventilatory support ( p = 0.05 ) . Caffeine was well tolerated. Conclusion: Caffeine reduced the duration of CPAP and the need for and duration of nutritional support through a direct effect on the digestive system or overall improvement. These results should be confirmed by randomised trials.
- 10 June 2025
- Published by Wiley in Acta Paediatrica
- Vol. 114 (11) , 2847-2855
Rapid Influenza Diagnosis in Children With Serious Bacterial Infection‐Like Symptoms
Aim: To evaluate the impact of the influenza diagnosis by the Quidel Sofia rapid influenza fluorescent immunoassay (FIA) on children presenting with serious bacterial infection (SBI)‐like symptoms in an emergency department (ED). Methods: A cohort study was conducted on 161 children with SBI‐like symptoms, who underwent a Quidel Sofia test. The management of Influenza‐positive and Influenza‐negative children was compared on diagnostic tests, antibiotic use, and hospitalisation rates. Follow‐up was performed 7–10 days post‐discharge to confirm SBI non‐omission. Results: Influenza‐positive children underwent fewer diagnostic tests, including fewer invasive tests, than influenza‐negative children (58.1% vs. 90.7%, p < 0.001 and 47.7% vs. 72%, p = 0.002, respectively), received fewer antibiotics (10.5% vs. 33.3%, p < 0.001), had lower hospitalisation rates (20.9% vs. 40%, p = 0.008) and shorter ED visits (133 [52–257] minutes vs. 177 [92–273] minutes, p = 0.002). No influenza‐positive patient had a missed SBI, even among the youngest patients. One developed a secondary SBI 4 days later resulting in death. Conclusion: This study demonstrated the benefit of the influenza diagnosis by Quidel Sofia rapid influenza FIA in medical management without omitting SBI in children with SBI‐like symptoms. Therefore, the Quidel Sofia test can help alleviate ED overcrowding during the influenza season while maintaining vigilance for bacterial co‐infection.
- 10 June 2025
- Published by Wiley in Acta Paediatrica
- Vol. 114 (11) , 2847-2855
Rapid Influenza Diagnosis in Children With Serious Bacterial Infection‐Like Symptoms
Aim: To evaluate the impact of the influenza diagnosis by the Quidel Sofia rapid influenza fluorescent immunoassay (FIA) on children presenting with serious bacterial infection (SBI)‐like symptoms in an emergency department (ED). Methods: A cohort study was conducted on 161 children with SBI‐like symptoms, who underwent a Quidel Sofia test. The management of Influenza‐positive and Influenza‐negative children was compared on diagnostic tests, antibiotic use, and hospitalisation rates. Follow‐up was performed 7–10 days post‐discharge to confirm SBI non‐omission. Results: Influenza‐positive children underwent fewer diagnostic tests, including fewer invasive tests, than influenza‐negative children (58.1% vs. 90.7%, p < 0.001 and 47.7% vs. 72%, p = 0.002, respectively), received fewer antibiotics (10.5% vs. 33.3%, p < 0.001), had lower hospitalisation rates (20.9% vs. 40%, p = 0.008) and shorter ED visits (133 [52–257] minutes vs. 177 [92–273] minutes, p = 0.002). No influenza‐positive patient had a missed SBI, even among the youngest patients. One developed a secondary SBI 4 days later resulting in death. Conclusion: This study demonstrated the benefit of the influenza diagnosis by Quidel Sofia rapid influenza FIA in medical management without omitting SBI in children with SBI‐like symptoms. Therefore, the Quidel Sofia test can help alleviate ED overcrowding during the influenza season while maintaining vigilance for bacterial co‐infection.
- 9 May 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108152
Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments
- 9 May 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 243, 108152
Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments
- 30 August 2024
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 32 (24) , e1280-e1288
Intranasal Fentanyl Versus Morphine in Fracture Reduction in a Pediatric Trauma Center
Purpose: Pain management in orthopaedic manipulation in the emergency department (ED) is crucial to decrease fracture reduction performed in the operating room. This study compared intranasal fentanyl (INF) with oral morphine in time of care and effectiveness on pain during the reduction of bone fractures in a pediatric trauma center. Methods: A before-and-after INF implementation study was conducted in a pediatric ED with a trauma center on children with a confirmed displaced closed fracture on radiographs with reduction and casting performed in the ED. The time of care, time for sufficient analgesia, effectiveness on pain, and tolerance were compared between both analgesics in 3 consecutive phases. Results: 77 children were included: 31 children received oral morphine and 46 INF. The time of care was shorter in the INF group (150 [111 to 193] minutes versus 215 [155 to 240], P = 0.01) as the time for sufficient analgesia (10 [9 to 13] minutes versus 80 [53 to 119], P < 0.001) with a higher pain reduction after a dose of INF (3 [0 to 4] versus 6 [3 to 7], P < 0.001) and less dose requirement (P = 0.002). Although pain scores were similar at arrival in both groups (P = 0.15), the pain was significantly lower before and during the procedure in the INF group and equivalent after the procedure (2 [0 to 4] versus 3 [0 to 5], P = 0.02, 3 [1 to 5] versus 7 [3 to 9], P < 0.001, and 1 [0 to 2] in both groups, P = 0.87, respectively). Keeping pain levels low during the procedure in the INF group allowed the extension to lower limb fracture reductions (P = 0.04). No serious adverse events were reported. Conclusion: INF reduces the time to obtain sufficient analgesia and time of care, with good effectiveness maintained during the procedure in fracture reduction, allowing the extension to lower limb fractures. Thus, this rapid and efficient analgesia facilitates orthopaedic care in the pediatric ED that would otherwise require to be reduced in the operating room under general anesthesia.
- 30 August 2024
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 32 (24) , e1280-e1288
Intranasal Fentanyl Versus Morphine in Fracture Reduction in a Pediatric Trauma Center
Purpose: Pain management in orthopaedic manipulation in the emergency department (ED) is crucial to decrease fracture reduction performed in the operating room. This study compared intranasal fentanyl (INF) with oral morphine in time of care and effectiveness on pain during the reduction of bone fractures in a pediatric trauma center. Methods: A before-and-after INF implementation study was conducted in a pediatric ED with a trauma center on children with a confirmed displaced closed fracture on radiographs with reduction and casting performed in the ED. The time of care, time for sufficient analgesia, effectiveness on pain, and tolerance were compared between both analgesics in 3 consecutive phases. Results: 77 children were included: 31 children received oral morphine and 46 INF. The time of care was shorter in the INF group (150 [111 to 193] minutes versus 215 [155 to 240], P = 0.01) as the time for sufficient analgesia (10 [9 to 13] minutes versus 80 [53 to 119], P < 0.001) with a higher pain reduction after a dose of INF (3 [0 to 4] versus 6 [3 to 7], P < 0.001) and less dose requirement (P = 0.002). Although pain scores were similar at arrival in both groups (P = 0.15), the pain was significantly lower before and during the procedure in the INF group and equivalent after the procedure (2 [0 to 4] versus 3 [0 to 5], P = 0.02, 3 [1 to 5] versus 7 [3 to 9], P < 0.001, and 1 [0 to 2] in both groups, P = 0.87, respectively). Keeping pain levels low during the procedure in the INF group allowed the extension to lower limb fracture reductions (P = 0.04). No serious adverse events were reported. Conclusion: INF reduces the time to obtain sufficient analgesia and time of care, with good effectiveness maintained during the procedure in fracture reduction, allowing the extension to lower limb fractures. Thus, this rapid and efficient analgesia facilitates orthopaedic care in the pediatric ED that would otherwise require to be reduced in the operating room under general anesthesia.
- Open Access
Clinical Manifestation of Cytomegalovirus-Associated Protein-Losing Enteropathy in Children
In children, CMV-associated protein-losing enteropathy (PLE) is characterised by a benign course and spontaneous healing but can lead to generalised oedema. Poorly defined, it is diagnosed after unnecessary invasive tests. Children with CMV-associated PLE between 2009 and 2019 in two French hospitals are retrospectively described. Clinical and biological signs, CMV identification, endoscopy and histological findings, disease management and course are analysed. CMV-associated PLE is proven in 21 immunocompetent and 22 immunosuppressed patients, with ages consistent with primo-infection and reactivation, respectively. The digestive symptoms prevail in immunocompetent children, mainly with vomiting (85.7% versus 50%, CI [1.2; 39.2], p = 0.02). Immunocompetent patients show more oedema (61.9% versus 4.5%, CI [3.6; 1502.4], p < 0.001), linked to more severe hypoalbuminemia (21.2 g/L [17.6–25.7] versus 29.6 g/L [24.9–33.9], p = 0.01). A severe course is observed in 23.8% of the immunocompetent patients and 54.5% of the immunosuppressed ones (p = 0.06). Evidence of CMV infection based on non-invasive methods is found on 88.9% of immunocompetent and 95.5% of immunosuppressed patients (p = 0.58), while endoscopy was performed on 95.2% and 100% of them, respectively (p = 0.48), without any therapeutic change. Thus, CMV-associated PLE should be suspected in children with generalised oedema. Not as benign as previously described, it can be confirmed using non-invasive tests.
Open AccessClinical Manifestation of Cytomegalovirus-Associated Protein-Losing Enteropathy in Children
In children, CMV-associated protein-losing enteropathy (PLE) is characterised by a benign course and spontaneous healing but can lead to generalised oedema. Poorly defined, it is diagnosed after unnecessary invasive tests. Children with CMV-associated PLE between 2009 and 2019 in two French hospitals are retrospectively described. Clinical and biological signs, CMV identification, endoscopy and histological findings, disease management and course are analysed. CMV-associated PLE is proven in 21 immunocompetent and 22 immunosuppressed patients, with ages consistent with primo-infection and reactivation, respectively. The digestive symptoms prevail in immunocompetent children, mainly with vomiting (85.7% versus 50%, CI [1.2; 39.2], p = 0.02). Immunocompetent patients show more oedema (61.9% versus 4.5%, CI [3.6; 1502.4], p < 0.001), linked to more severe hypoalbuminemia (21.2 g/L [17.6–25.7] versus 29.6 g/L [24.9–33.9], p = 0.01). A severe course is observed in 23.8% of the immunocompetent patients and 54.5% of the immunosuppressed ones (p = 0.06). Evidence of CMV infection based on non-invasive methods is found on 88.9% of immunocompetent and 95.5% of immunosuppressed patients (p = 0.58), while endoscopy was performed on 95.2% and 100% of them, respectively (p = 0.48), without any therapeutic change. Thus, CMV-associated PLE should be suspected in children with generalised oedema. Not as benign as previously described, it can be confirmed using non-invasive tests.
- Open Access
- 10 February 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (7)
Bacteroides thetaiotaomicron uses a widespread extracellular DNase to promote bile-dependent biofilm formation
Significance: Biofilms are communities of surface-attached bacteria exhibiting biofilm-specific properties. Although anaerobic biofilms impact health, industry, and environment, they are mostly studied in aerobic bacterial species. Here, we studied biofilm formation in Bacteroides thetaiotaomicron , an anaerobic gut symbiont degrading diet sugars and contributing to gut maturation. Although B. thetaiotaomicron adhesion contributes to intestinal colonization, little is known about the determinants of its biofilm capacities. We identified that bile is a physiologically relevant gut signal inducing biofilm formation in B. thetaiotaomicron and other gut Bacteroidales. Moreover, we showed that, in contrast to the known scaffolding role of extracellular DNA, bile-dependent biofilm requires a DNase degrading matrix DNA, thus revealing a previously unrecognized factor contributing to the adhesion capacity of major gut symbionts.
- 10 February 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (7)
Open AccessBacteroides thetaiotaomicron uses a widespread extracellular DNase to promote bile-dependent biofilm formation
Significance: Biofilms are communities of surface-attached bacteria exhibiting biofilm-specific properties. Although anaerobic biofilms impact health, industry, and environment, they are mostly studied in aerobic bacterial species. Here, we studied biofilm formation in Bacteroides thetaiotaomicron , an anaerobic gut symbiont degrading diet sugars and contributing to gut maturation. Although B. thetaiotaomicron adhesion contributes to intestinal colonization, little is known about the determinants of its biofilm capacities. We identified that bile is a physiologically relevant gut signal inducing biofilm formation in B. thetaiotaomicron and other gut Bacteroidales. Moreover, we showed that, in contrast to the known scaffolding role of extracellular DNA, bile-dependent biofilm requires a DNase degrading matrix DNA, thus revealing a previously unrecognized factor contributing to the adhesion capacity of major gut symbionts.
- Open Access
Nutrition of Preterm Infants and Raw Breast Milk-Acquired Cytomegalovirus Infection: French National Audit of Clinical Practices and Diagnostic Approach
Raw breast milk is the optimal nutrition for infants, but it is also the primary cause of acquired cytomegalovirus (CMV) infection. Thus, many countries have chosen to contraindicate to feed raw breast milk preterm infants from CMV-positive mothers before a corrected age of 32 weeks or under a weight of 1500 g. French national recommendations have not been updated since 2005. An audit of the French practices regarding the nutrition with raw breast milk in preterm infants was carried out using a questionnaire sent to all neonatal care units. Diagnosed postnatal milk-acquired CMV infections have been analysed using hospitalisation reports. Seventy-five percent of the neonatal units responded: 24% complied with the French recommendations, 20% contraindicated raw breast milk to all infants before 32 weeks regardless of the mothers’ CMV-status, whereas 25% fed all preterm infants unconditionally with raw breast milk. Thirty-five cases of infants with milk-acquired CMV infections have been reported. The diagnosis was undeniable for five patients. In France, a high heterogeneity marks medical practices concerning the use of raw breast milk and the diagnostic approach for breast milk-acquired CMV infection is often incomplete. In this context, updated national recommendations and monitored CMV infections are urgently needed.
Open AccessNutrition of Preterm Infants and Raw Breast Milk-Acquired Cytomegalovirus Infection: French National Audit of Clinical Practices and Diagnostic Approach
Raw breast milk is the optimal nutrition for infants, but it is also the primary cause of acquired cytomegalovirus (CMV) infection. Thus, many countries have chosen to contraindicate to feed raw breast milk preterm infants from CMV-positive mothers before a corrected age of 32 weeks or under a weight of 1500 g. French national recommendations have not been updated since 2005. An audit of the French practices regarding the nutrition with raw breast milk in preterm infants was carried out using a questionnaire sent to all neonatal care units. Diagnosed postnatal milk-acquired CMV infections have been analysed using hospitalisation reports. Seventy-five percent of the neonatal units responded: 24% complied with the French recommendations, 20% contraindicated raw breast milk to all infants before 32 weeks regardless of the mothers’ CMV-status, whereas 25% fed all preterm infants unconditionally with raw breast milk. Thirty-five cases of infants with milk-acquired CMV infections have been reported. The diagnosis was undeniable for five patients. In France, a high heterogeneity marks medical practices concerning the use of raw breast milk and the diagnostic approach for breast milk-acquired CMV infection is often incomplete. In this context, updated national recommendations and monitored CMV infections are urgently needed.